Field treatment of facial and scalp actinic keratoses with photodynamic therapy: Survey of patient perceptions of treatment satisfaction and outcomes

Australasian Journal of Dermatology

Volumn 52, Issue 3, 2011, Pages 195-201

  Tran, Dai T ^a   Salmon, Robert ^a  

^a Illawarra Dermatology and Laser Clinic   (Australia)

Author keywords

actinic keratoses; field therapy; patient satisfaction; photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER;

ACTINIC KERATOSIS; ARTICLE; CLINICAL ARTICLE; ERYTHEMA; HEALTH SURVEY; HUMAN; ILLUMINATION; INCUBATION TIME; MAGNETOTHERAPY; OUTCOME ASSESSMENT; PAIN; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PUSTULE; RETROSPECTIVE STUDY; SKIN ULCER; TELEDERMATOLOGY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FACIAL DERMATOSES; HUMANS; KERATOSIS, ACTINIC; MIDDLE AGED; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SCALP DERMATOSES;

EID: 80051795828     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2011.00785.x     Document Type: Article

References (32)

1. Staples M, Marks R, Giles G,. Trends in the incidence of non-melanocytic skin cancer treated in Australia 1985-95: are primary prevention programs starting to have an effect? Int. J. Cancer 1998; 78: 144-8. (Pubitemid 28443167)
2. Non-melanoma skin cancer General practice consultations, hospitalization and mortality Australian Institute of Health and Welfare and Cancer Australia. Sep 2008 Available from URL:. (Accessed 12 Jan 2011.)
3. Green A, Beardmore G, Hart V, et al,. Skin cancer in a Queensland population. J. Am. Acad. Dermatol. 1988; 19: 1045-52. (Pubitemid 19001531)
4. Marks R, Foley P, Goodman G, et al,. Spontaneous remission of solar keratoses: the case for conservative management. Br. J. Dermatol. 1986; 115: 649-55. (Pubitemid 17181888)
5. Marks R, Rennie G, Selwood TS,. Malignant Transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 9: 795-7. (Pubitemid 18094914)
6. Czarnecki D, Meehan CJ, Bruce F, et al,. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J. Cutan. Med. Surg. 2002; 6: 207-9. (Pubitemid 34839927)
7. Criscione VD, Weinstock MA, Naylor MF, et al,. Actinic keratoses. Cancer 2009; 115: 2523-30.
8. Röwert-Huber J, PATE LMJ, FORSCHNE RT, et al,. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br. J. Dermatol. 2007; 156: 8-12. (Pubitemid 46632512)
9. Glogau RG,. The risk of progression to invasive disease. J. Am. Acad. Dermatol. 2000; 42: 23-4.
10. Stockfleth E, Ferrandiz C, Grob JJ,. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur. J. Dermatol. 2008; 18: 651-9.
11. Basal cell carcinoma, squamous cell carcinoma (and related lesions). A guide to clinical management in Australia. Cancer Council Australia and Australian Cancer Network, Sydney. 2008. Available from URL:. (Accessed Jan 2011.)
12. Joseph MG, Zulueta WP, Kennedy PJ,. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. Aust. N. Z. J. Surg. 1992; 62: 697-701.
13. Rivard J, Ozog D,. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J. Drugs Dermatol. 2006; 5: 556-61.
14. Braathen LR, Szeimies RM, Basset-Seguin N, et al,. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J. Am. Acad. Dermatol. 2007; 56: 125-43. (Pubitemid 44969292)
15. Nowis D, Makowski M, Stokłosa T,. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochemi. Pol. 2005; 52: 339-52. (Pubitemid 41133769)
16. Ericson MB, Wennberg AM, Larko O,. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther. Clin. Risk. Manag. 2008; 4: 1-9. (Pubitemid 351460925)
17. Tarstedt M, Rosdahl I, Berne B,. A Randomized Multicenter Study to Compare Two Treatment regimens of Topical Methyl Aminolevulinate (Metvix)-PDT in Actinic Keratosis of the Face and Scalp. Acta Derm. Venereol. 2005; 85: 424-8. (Pubitemid 41345617)
18. Apalla Z, Sotiriou E, Chovarda E, et al,. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br. J. Dermatol. 2010; 162: 171-5.
19. Available from URL:. (Accessed 17 Mar 2011.)
20. Available from URL:. (Accessed 17 Mar 2011.)
21. Center for drug evaluation and research. Application number 21-415. Sep 2001. Available from URL:. (Accessed Jan 2011.)
22. Freeman M, Vinciullo C, Francis D, et al,. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J. Dermatol. Treat. 2003; 14: 99-106. (Pubitemid 36648700)
23. Touma D, Yaar M, Whitehead S, et al,. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch. Dermatol. 2004; 140: 33-40. (Pubitemid 38090268)
24. Shaffeburg M,. Treatment of actinic keratosis with sequential use of photodynamic therapy and imiquimoid 5% cream. J. Drug Dermatol. 2009; 8: 35-9.
25. Fritsch C, Homey B, Stahl W, et al,. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem. Photobiol. 1998; 68: 218-21. (Pubitemid 128472013)
26. van den Akker JT, Holroyd JA, Vernon DI, et al,. Chronic UVB exposure enhances in vitro percutaneous penetration of 5-aminulevulinic acid in hairless mouse skin. Lasers Surg. Med. 2004; 34: 141-5. (Pubitemid 38326358)
27. Waller JM, Dreher F, Behnam S, et al,. Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol. Physiol. 2006; 19: 283-9. (Pubitemid 44329095)
28. Smits T, Van Laarhoven AIM, Staassen A,. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells. Br. J. Dermatol. 2009; 160: 849-57.
29. Alexiades-Armenakas M,. Laser-mediated photodynamic therapy. Clin. Dermatol. 2006; 24: 16-25. (Pubitemid 43112351)
30. Barolet D, Boucher A,. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome. Lasers Surg. Med. 2010; 42: 171-8.
31. Wiegell SR, Stender IM, Na R, et al,. Pain Associated With Photodynamic therapy using 5-Aminolevulinic Acid or 5-Aminolevulinic Acid Methylester on Tape-Stripped Normal Skin. Arch. Dermatol. 2003; 139: 1173-7. (Pubitemid 37128379)
32. Fink-Puches R, Soyer HP, Hofer A, et al,. Long-term clinical follow-up and histological changes of superficial non-melanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch. Dermatol. 1998; 134: 821-6. (Pubitemid 28350185)